Publications
Marinou S, Mick P, Phillips NA. Does the serial position effect identify those at risk for dementia? Findings from the Canadian Longitudinal Study on Aging. Neuropsychology. 2026 Sep 10. doi: 10.1037/neu0001123. Epub ahead of print. PMID: 42721346.
Akbar N, Lin D, Cheung YHC, Mohamed A, Chowdhury M, Damouras S. Low body mass index is associated with higher rates of mild cognitive impairment and worse memory performance among older Canadian adults: An analysis of the Canadian Longitudinal Study on Aging (CLSA) database. J Alzheimers Dis. 2026 Aug;112(4):1945-1954. doi: 10.1177/13872877261464179. Epub 2026 Jul 11. PMID: 42434915; PMCID: PMC13433890.
Wang Q, Xie Y, Wu X, Jin S, Zhen W, Yu S, Sun Y, Sun W, Xu J, Zhang H. Toothache and Alzheimer’s Disease: A Mendelian Randomization Study of the NAAG-CD33 Neuroimmune Axis. J Pain Res. 2026 May 26;19:603587. doi: 10.2147/JPR.S603587. PMID: 42222647; PMCID: PMC13222017.
Wang Y, Wang L, Zhan D. Differential Causal Associations of Gut Microbiota, Blood Metabolites, and Immune Cell Phenotypes With Early- and Late-Onset Alzheimer’s Disease: A Bidirectional Mendelian Randomization Analysis. Cureus. 2026 May 24;18(5):e109543. doi: 10.7759/cureus.109543. PMID: 42344833; PMCID: PMC13289579.
Alaka SA, Ngan SC, MacPherson RE, Pickett W, Chen CP, Sze SK. Enhancing dementia risk prediction with heart rate and machine learning in the Canadian Longitudinal Study on Aging. J Alzheimers Dis. 2025 Oct 29:13872877251390562. doi: 10.1177/13872877251390562. Epub ahead of print. PMID: 41160465.
Son S, Speechley M, Zou G, Montero-Odasso M. What Combinations of Modifiable Risk Factors Are Most Prevalent and Most Strongly Associated with Low Cognition? Results from Canadian Longitudinal Study on Aging. Dement Geriatr Cogn Disord. 2026 Jan 20:1-13. doi: 10.1159/000550244. Epub ahead of print. PMID: 41557558.
Son S, Speechley M, Zou G, Montero-Odasso M. Identifying the optimal combinations of modifiable dementia risk factors to target in multidomain intervention – Three-year longitudinal findings from the Canadian longitudinal study on aging. J Prev Alzheimers Dis. 2025 Aug 15:100321. doi: 10.1016/j.tjpad.2025.100321. Epub ahead of print. PMID: 40817010.
Son S, Speechley M, Zou GY, Kivipelto M, Mangialasche F, Feldman HH, Chertkow H, Belleville S, Nygaard H, Hachinski V, Pieruccini-Faria F, Montero-Odasso M. Potentially Modifiable Dementia Risk Factors in Canada: An Analysis of Canadian Longitudinal Study on Aging with a Multi-Country Comparison. J Prev Alzheimers Dis. 2024;11(5):1490-1499. doi: 10.14283/jpad.2024.105. PMID: 39350396; PMCID: PMC11436427.
Dolatshahi Y, Mayhew A, O’Connell ME, Liu-Ambrose T, Taler V, Smith EE, Hogan DB, Kirkland S, Costa AP, Wolfson C, Raina P, Griffith L, Jones A. Prevalence and population attributable fractions of potentially modifiable risk factors for dementia in Canada: A cross-sectional analysis of the Canadian Longitudinal Study on Aging. Can J Public Health. 2024 Dec;115(6):953-963. doi: 10.17269/s41997-024-00920-7. Epub 2024 Jul 24. PMID: 39048849; PMCID: PMC11644133.
Tio ES, Hohman TJ, Milic M, Bennett DA, Felsky D; Alzheimer’s Disease Neuroimaging Initiative. Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer’s Disease and Aging. J Alzheimers Dis. 2023;94(4):1549-1561. doi: 10.3233/JAD-230434. PMID: 37458040.